Homecare Diagnostics and Therapeutics Market Size, Share, and Trends 2026 to 2035

Revenue, 2025

USD 269.92 Bn

Forecast Year, 2035

USD 577.56 Bn

CAGR, 2026 - 2035

7.90%

Report Coverage

Global

What is the Homecare Diagnostics and Therapeutics Market Size?

The global homecare diagnostics and therapeutics market size is calculated at USD 269.92 billion in 2025 and is predicted to increase from USD 291.51 billion in 2026 to approximately USD 577.56 billion by 2035, expanding at a CAGR of 7.90% from 2026 to 2035.

Homecare Diagnostics and Therapeutics Market Key Takeaways

• North America dominated the market in 2025.
• Asia Pacific is expected to witness rapid growth throughout the forecast period.
• By product, the diagnostics segment dominated the market in 2025.
• By service, the skilled nursing services segment led the market in 2025.
• By indication, the cardiovascular disorders segment held a large share of the market in 2025.

What are Homecare Diagnostics and Therapeutics?

The homecare diagnostics and therapeutics market deals with a wide range of healthcare products, such as nebulizers and blood glucose level indicators, which offer individuals adequate physical support, diagnosis, and healthcare monitoring. These user-friendly and portable devices allow patients to receive treatment from the comfort of their own homes and prevent costly hospital spending. The market has witnessed significant growth in the past few years. The demand for medical devices has increased exponentially during the COVID-19 pandemic due to the rising awareness about health & wellness. Moreover, the market is expected to grow in the coming years owing to the increasing usage of mHealth techniques, such as smartphone apps and wearables, the rising adoption of user-friendly and portable diagnostics & therapeutics devices, and the growing usage of telemedicine services.

How is AI contributing to the home Homecare Diagnostics and Therapeutics Industry?

Artificial Intelligence enables health care professionals to work faster and more efficiently by applying algorithms that can learn, interpret, and support through diagnostics and therapeutics, among others, the medical information. It helps the radiology and rehabilitation departments, enhances decision-making by extracting the most relevant evidence from clinical literature, and keeps doctors updated with medical knowledge.

Such tools can help streamline the data review process, improve workflow, accelerate the diagnosis process, and provide smart assistance for planning treatments. The integration plays an important role by supporting personalized care at home through allowing informed decision-making, better patient monitoring, and providing efficient guidance for therapy management.

Homecare Diagnostics and Therapeutics Market Growth Factors

The global homecare diagnostics and therapeutics market is primarily driven by several factors, such as the growing geriatric population, the rising prevalence of various chronic diseases, the increasing demand for convenient and quality healthcare services, and the rising technological advancements in home care tools. Some chronic diseases often require continuous monitoring of health status to prevent life-threatening events. However, telehealth plays a crucial role in homecare diagnostics & therapeutics, as it allows patients to access healthcare services remotely and manage their conditions remotely, thus reducing frequent and unnecessary hospital visits. The proliferation of digital technologies, the rising adoption of smartphones, and improving access to the internet are the major factors that boosted the adoption of telehealth applications across the globe. Moreover, favorable government frameworks for encouraging the adoption of telehealth to reduce the pressure on hospitals have significantly driven the adoption of telehealth.

Furthermore, the rising awareness regarding hospital-acquired infections among the population is compelling consumers to opt for homecare health services. According to the World Health Organization, around 7% of hospitalized patients in developed countries and 10% in developing countries are expected to acquire at least one healthcare-associated infection. Urinary tract infections are the most frequent hospital-acquired infection in developed countries. Moreover, the growing geriatric population is a major factor propelling the homecare diagnostics and therapeutics market.

• According to the World Health Organization, the number of people aged 60 or above is expected to reach about 2.1 billion by 2050.

Homecare Diagnostics and Therapeutics Market Outlook

[[market_outlook]]

Market Scope

Market Dynamics

Driver

Reduction of hospital readmissions and enhanced safety

For patients with chronic diseases, hospital readmissions are a common concern. In certain health conditions, people face difficulties in moving out; hence, homecare diagnostics and therapeutics play a crucial role in treating such patients. Home care services offer immediate intervention and allow patients to monitor their health from the comfort of their own homes, which can avoid complications that may cause readmission. This approach further reduces frequent hospital and emergency room visits and minimizes additional healthcare costs. In addition, homecare provides a safer alternative to institutional care. Moreover, the increasing demand for cost-effective healthcare services, the trend of self-care, and the rising adoption of medical devices drive the market during the forecast period.

Restraint

High cost and lack of reimbursement policies

The high cost associated with homecare services restrains the market. The low affordability of people in developing and underdeveloped countries may deter them from adopting homecare diagnostics & therapeutics services, creating significant market challenges. Furthermore, the lack of reimbursement policies for homecare services makes them expensive, thus creating barriers for low-income people to adopt them.

Opportunity

Advancements in home care tools

The rising technological advancements in home care tools create lucrative opportunities in the market. Advanced technologies, such as data analytics, wireless connectivity, and artificial intelligence, are significantly boosting the adoption of several homecare diagnostic and therapeutic devices around the world. Healthcare providers are also adopting these technologies to reduce healthcare costs. For instance,

• In June 2024, an Oklahoma City-based startup, Apricot, leveraged generative AI to minimize healthcare documentation, allowing home-health nurses to concentrate more on patient care.

Homecare Diagnostics and Therapeutics Market Segment Insights

[[segment_insights]]

Homecare Diagnostics and Therapeutics Market Regional Insights

[[regional_insights]]

Homecare Diagnostics and Therapeutics Market Value Chain

[[value_chain]]

Homecare Diagnostics & Therapeutics Market Companies

[[market_company]]

Other Major Companies

• F. Hoffmann-La Roche Ltd.
• A&D Company
• BAYADA Home Health Care
• Invacare Corporation
• Abbott
• Amedisys
• ResMed

Recent Developments in the Homecare Diagnostics and Therapeutics Industry

• In August 2025, Nonin Medical launched the Nonin Health platform, a cloud-based system aiding DME/HME providers, sleep dentists, and labs in managing oxygen and sleep-related care for millions of patients efficiently. The platform enables remote access to testing results, making healthcare providers deliver therapy timely and cost-effectively.
  (Source: respiratory-therapy.com )
• In April 2025, Cipla Foundation, in collaboration with CanSupport, initiated free palliative home care services in Pune, targeting over 900 cancer patients through nine teams across Pune City and four talukas: Haweli, Khed, Bhor, and Purandar.
  (Source: expresshealthcare.in )
• In September 2023, Apollo Hospitals launched India's first Comprehensive Connected Care program powered by Apollo's Connected Care technology. This service offers nursing staff and clinical teams across various care touchpoints and patient journeys, such as home care, post-surgery, Inpatient, emergency, and ambulance.
• In July 2023, Allied Insurance Company and Star Health launched home healthcare services in 50 towns and cities in India. The aim behind this launch was to provide healthcare service at the doorstep of the customers.

Segments Covered in the Report

[[segment_covered]]